DAPT 'Too Strong' After CABG for Heart Attacks, Trial Says

(MedPage Today) — MADRID — Dual antiplatelet therapy (DAPT) didn’t improve outcomes after coronary artery bypass grafting (CABG) for an acute coronary syndrome (ACS) but did increase risks, the TACSI randomized trial showed.
With ticagrelor…

Source link : https://www.medpagetoday.com/meetingcoverage/esc/117248

Author :

Publish date : 2025-09-01 20:34:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

DAPT ‘Too Strong’ After CABG for Heart Attacks, Trial Says

SWEDEPAD Trials Resurrect the Paclitaxel Death Signal in PAD Interventions

Personalized Colon Cancer Risk Message Fails to Boost Screening Uptake

Related Posts

Officials Kept Outbreak a Secret; Mysterious Cancer Rise; Stillbirths Undercounted

Oxford Trial Tests AI to Find Cancers in Dense Breasts

IPE May Cut Days Lost to Hospitalization or Death in CVD

Geographic Clusters Show Uneven Cancer Screening in the US

Healthy Diet May Cut Heart Risk in Patients With CVD

Older Antihistamines Tied to Delirium in Older Patients

Officials Kept Outbreak a Secret; Mysterious Cancer Rise; Stillbirths Undercounted

Oxford Trial Tests AI to Find Cancers in Dense Breasts

IPE May Cut Days Lost to Hospitalization or Death in CVD

Geographic Clusters Show Uneven Cancer Screening in the US

Healthy Diet May Cut Heart Risk in Patients With CVD

Older Antihistamines Tied to Delirium in Older Patients

Use of IV Magnesium Sulphate Tied to Lower Mortality in ARDS

‘We begged for years but the help wasn’t there’

Categories

Archives